TWST logo

Twist Bioscience (TWST) Cash from operations

annual CFO:

-$64.09M+$78.38M(+55.01%)
September 30, 2024

Summary

  • As of today (June 22, 2025), TWST annual cash flow from operations is -$64.09 million, with the most recent change of +$78.38 million (+55.01%) on September 30, 2024.
  • During the last 3 years, TWST annual CFO has risen by +$48.15 million (+42.90%).
  • TWST annual CFO is now -66.08% below its all-time high of -$38.59 million, reached on September 30, 2016.

Performance

TWST Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTWSTcash flow metrics

quarterly CFO:

-$12.99M+$8.44M(+39.40%)
March 31, 2025

Summary

  • As of today (June 22, 2025), TWST quarterly cash flow from operations is -$12.99 million, with the most recent change of +$8.44 million (+39.40%) on March 31, 2025.
  • Over the past year, TWST quarterly CFO has increased by +$6.44 million (+33.14%).
  • TWST quarterly CFO is now -924.94% below its all-time high of -$1.27 million, reached on September 30, 2022.

Performance

TWST quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTWSTcash flow metrics

TTM CFO:

-$56.11M+$6.44M(+10.29%)
March 31, 2025

Summary

  • As of today (June 22, 2025), TWST TTM cash flow from operations is -$56.11 million, with the most recent change of +$6.44 million (+10.29%) on March 31, 2025.
  • Over the past year, TWST TTM CFO has increased by +$30.40 million (+35.14%).
  • TWST TTM CFO is now -250.35% below its all-time high of -$16.02 million, reached on December 31, 2017.

Performance

TWST TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTWSTcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

TWST Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+55.0%+33.1%+35.1%
3 y3 years+42.9%+69.3%+63.0%
5 y5 years+27.1%+77.9%+59.6%

TWST Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+55.0%-924.9%+76.0%at high+64.5%
5 y5-yearat high+55.0%-924.9%+77.9%at high+64.5%
alltimeall time-66.1%+55.0%-924.9%+77.9%-250.3%+64.5%

TWST Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
-$12.99M(-39.4%)
-$56.11M(-10.3%)
Dec 2024
-
-$21.43M(+39.9%)
-$62.55M(-2.4%)
Sep 2024
-$64.09M(-55.0%)
-$15.32M(+140.2%)
-$64.09M(-7.7%)
Jun 2024
-
-$6.38M(-67.2%)
-$69.48M(-19.7%)
Mar 2024
-
-$19.42M(-15.5%)
-$86.51M(-22.3%)
Dec 2023
-
-$22.97M(+11.0%)
-$111.38M(-21.8%)
Sep 2023
-$142.47M(+14.5%)
-$20.70M(-11.6%)
-$142.47M(+15.8%)
Jun 2023
-
-$23.41M(-47.1%)
-$123.04M(-8.0%)
Mar 2023
-
-$44.29M(-18.1%)
-$133.75M(+1.5%)
Dec 2022
-
-$54.07M(+4167.6%)
-$131.80M(+6.0%)
Sep 2022
-$124.39M(+10.8%)
-$1.27M(-96.3%)
-$124.39M(-21.2%)
Jun 2022
-
-$34.13M(-19.4%)
-$157.92M(+4.1%)
Mar 2022
-
-$42.34M(-9.2%)
-$151.76M(+13.3%)
Dec 2021
-
-$46.65M(+34.0%)
-$133.97M(+19.4%)
Sep 2021
-$112.24M
-$34.80M(+24.5%)
-$112.24M(+9.4%)
Jun 2021
-
-$27.96M(+13.9%)
-$102.64M(+4.6%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$24.55M(-1.5%)
-$98.15M(-25.8%)
Dec 2020
-
-$24.93M(-1.1%)
-$132.27M(-7.0%)
Sep 2020
-$142.25M(+61.8%)
-$25.20M(+7.4%)
-$142.25M(+1.3%)
Jun 2020
-
-$23.47M(-60.0%)
-$140.41M(+1.0%)
Mar 2020
-
-$58.67M(+68.0%)
-$139.03M(+37.4%)
Dec 2019
-
-$34.91M(+49.5%)
-$101.17M(+15.0%)
Sep 2019
-$87.94M(+32.9%)
-$23.36M(+5.8%)
-$87.94M(+8.2%)
Jun 2019
-
-$22.08M(+6.1%)
-$81.28M(+6.8%)
Mar 2019
-
-$20.81M(-4.0%)
-$76.14M(+6.0%)
Dec 2018
-
-$21.68M(+29.9%)
-$71.83M(+8.6%)
Sep 2018
-$66.16M(+29.0%)
-$16.70M(-1.5%)
-$66.16M(+33.8%)
Jun 2018
-
-$16.94M(+2.6%)
-$49.47M(+52.1%)
Mar 2018
-
-$16.51M(+3.1%)
-$32.53M(+103.1%)
Dec 2017
-
-$16.02M
-$16.02M
Sep 2017
-$51.30M(+32.9%)
-
-
Sep 2016
-$38.59M
-
-

FAQ

  • What is Twist Bioscience annual cash flow from operations?
  • What is the all time high annual CFO for Twist Bioscience?
  • What is Twist Bioscience annual CFO year-on-year change?
  • What is Twist Bioscience quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Twist Bioscience?
  • What is Twist Bioscience quarterly CFO year-on-year change?
  • What is Twist Bioscience TTM cash flow from operations?
  • What is the all time high TTM CFO for Twist Bioscience?
  • What is Twist Bioscience TTM CFO year-on-year change?

What is Twist Bioscience annual cash flow from operations?

The current annual CFO of TWST is -$64.09M

What is the all time high annual CFO for Twist Bioscience?

Twist Bioscience all-time high annual cash flow from operations is -$38.59M

What is Twist Bioscience annual CFO year-on-year change?

Over the past year, TWST annual cash flow from operations has changed by +$78.38M (+55.01%)

What is Twist Bioscience quarterly cash flow from operations?

The current quarterly CFO of TWST is -$12.99M

What is the all time high quarterly CFO for Twist Bioscience?

Twist Bioscience all-time high quarterly cash flow from operations is -$1.27M

What is Twist Bioscience quarterly CFO year-on-year change?

Over the past year, TWST quarterly cash flow from operations has changed by +$6.44M (+33.14%)

What is Twist Bioscience TTM cash flow from operations?

The current TTM CFO of TWST is -$56.11M

What is the all time high TTM CFO for Twist Bioscience?

Twist Bioscience all-time high TTM cash flow from operations is -$16.02M

What is Twist Bioscience TTM CFO year-on-year change?

Over the past year, TWST TTM cash flow from operations has changed by +$30.40M (+35.14%)
On this page